Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp109 | Endocrine Tumours | ECE2016

Expression and mutational status of USP8 in tumours causing ectopic Cushing’s syndrome

Perez-Rivas Luis Gustavo , Theodoropoulou Marily , Oszwald Andrea , Fazel Julia , Komada Masayuki , Kirchner Thomas , Beuschlein Felix , Reincke Martin

Introduction: Mutations activating USP8 have been detected in a high proportion of pituitary adenomas causing Cushing’s disease and have been linked to an increase of ACTH production in corticotroph cells. Whether USP8 mutations are involved in the tumorigenesis of the ectopic Cushing’s syndrome (ECS) caused by neuroendocrine tumors has not been studied.Patients and methods: In this work we evaluate the role of USP8 in a series of 17 t...

ea0020htb1 | Hot topics: Basic | ECE2009

Hot topics: Basic

Spyroglou Ariadni , Wagner Sibylle , Manolopoulou Jenny , Hantel Constanze , Reincke Martin , Bidlingmaier Martin , Hrabe de Angelis Martin , Beuschlein Felix

Although primary aldosteronism (PA) is considered to be the most prevalent cause of secondary hypertension the underlying genetic mechanisms have been elucidated only for the rare familial forms of the disease. In an attempt to define novel genetic loci involved in the pathophysiology of PA a phenotype-driven mutagenesis screening after treatment with the alkylating agent N-ethyl-N-nitrosourea was established for the parameter aldosterone. The aldosterone values ...

ea0016p28 | Adrenal | ECE2008

Establishment of a mutagenesis screen to identify mice with high aldosterone levels

Spyroglou Ariadni , Wagner Sibylle , Manolopoulou Jenny , Hantel Constanze , Reincke Martin , Bidlingmaier Martin , de Angelis Martin Hrabe , Beuschlein Felix

According to recent studies, primary aldosteronism is considered to be responsible for almost 10% of all cases of arterial hypertension. The genetic background of this common disease, however, has been elucidated only for the rare familial types whereas in the large majority of sporadic cases it still remains unclear. In an attempt to define novel genetic mechanisms of hyperaldosteronism we utilized a random mutagenesis screen after treatment with the alkylating agent N...

ea0056gp197 | Pituitary Basic | ECE2018

Efficacy of pharmacological USP8 inhibition in human Cushing’s disease tumours in vitro

Theodoropoulou Marily , Perez-Rivas Luis , Albani Adriana , Stalla Gunter , Buchfelder Michael , Flitsch Joerg , Honegger Juergen , Rachinger Walter , Reincke Martin

The tumorigenesis of Cushing’s disease is characterized by somatic mutations in the USP8 gene in almost half of the cases. USP8 encodes for ubiquitin specific protease 8, a deubiquitinase that rescues proteins involved in the regulation of ACTH synthesis in corticotroph cells. In the present study we tested the antisecretory and antiproliferative efficacy of a commercially available specific USP8 inhibitor (IC50 3.1 μM USP8; >90 μM USP7) in immortalized muri...

ea0075a17 | Adrenal gland | EYES2021

Characterization of transcriptional and miRNA based dysregulations in Cushing’s syndrome

Vetrivel Sharmilee , Zhang Ru , Osswald Andrea , Engel Mareen , Beuschlein Felix , Chen Alon , Sbiera Silviu , Reincke Martin , Riester Anna

Introduction: Transcriptional regulation of gene expression by miRNAs is critical for the fine-tuning of adrenal stress response. However, its role in hypercortisolism has not been explored well. The study addresses this gap using adrenal samples of 3 patient groups from the German Cushing’s registry: Cortisol-Producing-Adenoma (CPA), Primary Bilateral Adrenal Hyperplasia (PBMAH) and controls (adrenal samples of patients with pheochromocytoma).Metho...

ea0099p419 | Adrenal and Cardiovascular Endocrinology | ECE2024

Primary aldosteronism: Small molecule antagonists of mutant KCNJ5 potassium channels

Mir-Bashiri Sanas , Tetti Martina , Froebel Dennis , Reiss Dunja , Bechmann Nicole , Peitzsch Mirko , Eisenhofer Graeme , Reincke Martin , Williams Tracy Ann

Background: Primary aldosteronism (PA) is the most frequent cause of endocrine hypertension associated with excess aldosterone production from one or both adrenal glands. Somatic or germline mutations in the KCNJ5 potassium channel cause an imbalance in intracellular ion homeostasis. This ultimately drives aldosterone overproduction in some sporadic forms of PA and a familial form of the disease (familial hyperaldosteronism type 3). Our objective was to identify small molecule...

ea0099ep410 | Adrenal and Cardiovascular Endocrinology | ECE2024

Impact of sampling device on quantification of 11-oxygenated androgens in saliva by liquid chromatography tandem mass spectrometry

Kunz Sonja , Dubinski Ilja , Schiergens Katharina , Hawley James , Keevil Brian , Reisch Nicole , Reincke Martin , Schmidt Heinrich , Bidlingmaier Martin

Introduction: 11-ketotestosterone (11KT) and 11β-hydroxyandrostenedione (11OHA4) are new biomarkers for hyperandrogenic disorders. Steroids can be measured in saliva, allowing non-invasive sampling by patients. We modified a published LC-MS/MS method1 for quantification of 11-oxygenated androgens in saliva with respect to sample volume, extraction procedure and equipment, and assessed the potential impact of different sampling devices on results.<p class="a...

ea0099ep600 | Pituitary and Neuroendocrinology | ECE2024

Hypogonadism in male patients with cushing’s syndrome: prevalence and outcome

Nowak Elisabeth , Vogel Frederick , Braun Leah , Zopp Stephanie , Rubinstein German , Adam Pia , Schweizer Junia , Ritzel Katrin , Beuschlein Felix , Reincke Martin

Background: Secondary hypogonadism (SH) is a common comorbidity of Cushing’s syndrome (CS) in men. There is a large overlap in associated symptoms and comorbidities between hypogonadism and hypercortisolism. To date, the influence of coexistent SH on clinical and biochemical parameters in CS is largely unknown and longitudinal data investigating its recovery during the remission phase are scarce.Hypothesis: We hypothesized that SH is a frequent and ...

ea0081oc13.3 | Oral Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

11-oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease

Nowotny Hanna , Vogel Frederick , Bidlingmaier Martin , Braun Leah , Reincke Martin , Tschaidse Lea , Auer Matthias , Lottspeich Christian , Hawley James M , Adaway Jo , Keevil Brian , Schilbach Katharina , Reisch Nicole

Background: Symptoms of hyperandrogenism are common in patients with Cushing’s disease (CD), but they cannot be sufficiently explained by measured concentrations of circulating androgens. In this study we analyzed the contribution of 11-oxygenated (11o×C19) androgens to hyperandrogenemia in female patients with CD as well as the influence of treatment with steroidogenesis inhibitors osilodrostat and metyrapone on 11o×C19 and classic androgens.<p class="abste...

ea0081p20 | Adrenal and Cardiovascular Endocrinology | ECE2022

Characterization of adrenal miRNA-based dysregulations in Cushing’s Syndrome

Zhang Ru , Vetrivel Sharmilee , Watts Deepika , Osswald Andrea , Engel Mareen , Beuschlein Felix , Chen Alon , Sbiera Silviu , Wielockx Ben , Reincke Martin , Riester Anna

Introduction: Transcriptional regulation of gene expression by miRNAs is critical for the fine-tuning of stress response. However, its role in hypercortisolism has not been explored well. After exploring circulating miRNAs in Cushing’ Syndrome (CS) as biomarkers our aim was to investigate their origin and their role in adrenal tissue.Methods: Next generation sequencing (NGS) based miRNA profiling was performed in adrenal samples from patients of Ger...